Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. - Wikidata - awgldk - TriplyDB

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

http://www.wikidata.org/entity/Q33622107

about

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67 Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the US Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.See-and-treat approaches to cervical cancer prevention for HIV-infected women.Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.Oncogenic HPV among HIV infected female population in West Bengal, India The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda.HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women Cervical cancer risk factors among HIV-infected Nigerian women Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70.Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010.Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.The spectrum of cancers in West Africa: associations with human immunodeficiency virus Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya High-risk human papillomavirus infection in HIV-positive African women living in Europe.HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women.Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India T cell susceptibility to HIV influences outcome of opportunistic infections.Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report.Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa.Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women.Cervical cytological abnormalities and human papilloma virus infection in women infected with HIV in Southern India.Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century.Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men?Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda

P2860

Q21135368-7320D3BE-634D-4F37-9836-206405AC9497 Q30388952-1324D202-CEEE-4340-81F5-C43B5215ECE4 Q33590354-A214336F-CB7F-44B8-BFA3-0869E118D595 Q33661008-9E00AFB4-CD8C-4174-A71A-31343329939B Q33728067-2E9A9E81-603A-427E-80AD-20AD1AA63101 Q33754163-2B9B2039-A09A-45D5-8A55-78D225F94554 Q33762765-4061053A-513A-4574-AB88-D5F6C6EF98A6 Q33850433-6964A34E-0E0B-4621-8C35-49CED2C52042 Q34089666-F321D040-276F-4CB0-9D56-AFB19EE89F57 Q34313933-69ED0EA3-01D8-4F0C-87AD-823F73B1D39D Q34541799-ADF72DA5-8CFE-4A13-BF57-5E5338A003D1 Q34764388-A7C39D1B-6528-4687-AC37-448B8AAA2248 Q34773250-D95C6246-F928-4B36-B82C-41B7594EB218 Q34973937-BFFE48BA-D3AE-4D56-911A-1CD792E9D0B3 Q35413976-381A9EC2-5001-4DAA-96BF-D025B7DD9DE0 Q35865134-56826EC5-2CD1-4FEE-BCA8-E99CF419C98B Q36028540-7941AB4B-1737-4772-AB63-3EA385582A95 Q36117247-7CED6945-7293-4EEC-B1F8-DCF14A0E86BB Q36326481-BC9A2ABA-3363-4B1B-B592-ED624891B6B3 Q36353603-5388BC18-EA8A-43EC-AEC4-45812927ACE9 Q36385334-86EB814E-C770-4CBD-883F-60703F56DEA7 Q36614735-365607A4-5BD0-4C46-B181-3EBAEE292CFF Q36675916-4C7969CD-8393-4AA6-96D8-98111EC6B8DE Q36769394-3402DA02-2512-42D1-AD54-51CAEE13F588 Q36769720-D3C3E01F-0BBA-4E47-A9C9-48AF528E564D Q37382387-46BCC059-A6BA-4F37-851E-68222588EB21 Q37619549-74E38230-C545-4C92-8847-9B908A3E9121 Q37636469-B249B8CC-D947-4DC0-991A-FB2CF4CA254E Q39443867-8167C31D-1F22-4817-9E11-7AD2F8B4C7B5 Q40091398-A8E50F28-BF81-439D-B8ED-31EF2FC78BD9 Q40536429-A1DE6B38-ECBD-4FF0-96BE-7450B8772293 Q42277972-4DF05F1A-88D4-4738-957D-F85DA545B449 Q46965101-49631ADE-9820-43B8-B631-16C1D72E75AC Q46989685-D0AC26B2-4F2F-4F88-9B88-D94447E100DE Q52605454-1BFF4392-F7E8-4A04-B7EC-59373D7045CB Q58006066-BFCC5A91-A075-4DEA-8C1A-B52D2000666C Q58085168-B3A4486F-F3CF-4001-8DB4-6E4EFBB0A273 Q58800228-CE038AD9-3537-41A8-BB61-0B90ED8FB23C

P2860

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

http://www.wikidata.org/entity/Q33622107

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@ast

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@en

type

label

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@ast

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@en

prefLabel

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@ast

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@en

P1433

Q33622107-E2B1D8B9-6BCE-4EC7-B327-CF804BDCE75E

P1476

Q33622107-6C310DBA-AD01-4EF9-9F7D-754CDE4CB6EA

P2093

Q33622107-04B62A00-5C7E-4F79-8463-40E66654B087

Q33622107-0F5C9B75-FDD2-477F-BA5F-DE6DAEBBBB33

Q33622107-27286D5B-F7EC-492C-BBB3-1CB28DFE4A3B

Q33622107-3FF8F0D6-911B-4AB8-9ACF-FE7CFB1F9DBE

Q33622107-5EBC4F41-35D8-4125-8EA7-CA402B6406B4

Q33622107-684D4868-EF66-41E1-AECC-7F779458B02C

Q33622107-7285250E-BCC8-4DC1-B07F-E2531D9842F4

Q33622107-A9DAB5B1-965F-48CD-B581-34CBB038FCC9

Q33622107-B22CFB79-827B-4CE9-9CC1-BD744C142D91

Q33622107-C4AA2494-5383-4D46-B348-73A83D9CEED0

P2860

Q33622107-0117F465-F1A1-4B76-8D40-ECC5945F2A0F

Q33622107-024BAE44-A82B-471B-826A-21F4CE226F19

Q33622107-05039205-F79D-4ED7-B483-8C965A44BF0F

Q33622107-184FDF4D-5DFA-4AC2-8185-3DAF766F3980

Q33622107-4080531A-D1F5-4F25-9E5D-2F614F05AF48

Q33622107-433AC98A-5406-4767-A5DE-2D7D8BE1A844

Q33622107-4B7D4004-B581-4556-8E87-7A0235E4B18D

Q33622107-58A70679-654E-41F3-9343-E1B45A86B7D5

Q33622107-6024E359-6DAC-4BB2-8E5F-37FA4B21FC67

Q33622107-6E5AD29E-9E68-42DD-A4D9-B5E9AA3E6108

P304

Q33622107-303AE74C-563D-4695-9A89-C9BCEDE235DF

P31

Q33622107-99B41B0E-CFC7-498F-AEDB-CA7608001BB8

P356

Q33622107-3A361CD6-34A5-48A9-ADA4-984B30552174

P407

Q33622107-CC3996C3-3C55-4771-B0F0-7D1A24ECA9A0

P433

Q33622107-E7900A70-FF8B-4E34-BFDF-00E854A12053

P478

Q33622107-CF7CFFF0-7EDB-4C9D-A919-C98441B8FE7F

P577

Q33622107-A7C6E69C-9574-44AC-A80B-FC9E0133D929

P5875

Q33622107-AB1DB033-A028-4B0D-AF9C-C09B1324A1D9

P698

Q33622107-33F9C01F-6865-4023-882A-B02CD59F7EC0

P921

Q33622107-1E2557FD-2FCD-418E-8228-C4D6303B8493

P932

Q33622107-D7E88EAE-CA9A-4249-B642-7C3EF1FEBECF

P356

P1433

The Journal of Infectious Diseases

P1476

Human papillomavirus infection ...... HIV-uninfected Rwandan women.

@en

P2093

Antonio Cajigas

http://www.w3.org/2001/XMLSchema#string

Diljeet K Singh

http://www.w3.org/2001/XMLSchema#string

Donald R Hoover

http://www.w3.org/2001/XMLSchema#string

Eugene Mutimura

http://www.w3.org/2001/XMLSchema#string

Janvier Rwamwejo

http://www.w3.org/2001/XMLSchema#string

Kathryn Anastos

http://www.w3.org/2001/XMLSchema#string

Louis Ngendahayo

http://www.w3.org/2001/XMLSchema#string

Magalis Vuolo

http://www.w3.org/2001/XMLSchema#string

Mardge Cohen

http://www.w3.org/2001/XMLSchema#string

Philip E Castle

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

The global health burden of infection-associated cancers in the year 2002

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

P304

1851-1861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/599123

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

199

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24420874

http://www.w3.org/2001/XMLSchema#string

P698

19435429

http://www.w3.org/2001/XMLSchema#string

P921

P932

2814215

http://www.w3.org/2001/XMLSchema#string